Hypertrophic Cardiomyopathy CardioNerds Content

Hypertrophic Cardiomyopathy

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

CardioNerds (Amit Goyal & Daniel Ambinder) join Brown University cardiology fellows (Greg Salber, Vrinda Trivedi, ...

Devesh Rai, MDHypertrophic Cardiomyopathy | June 28, 2023

The United States Food and Drug Administration (FDA) approved Mavacamten to treat patients with symptomatic obstructive ...

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

CardioNerds (Amit Goyal & Daniel Ambinder) join Virginia Commonwealth University (VCU) cardiology fellows (Ajay ...

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Amit joins Dr. Laura Young to take a pulse check with these great experts.

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Dr. Edward Kasper shares a unique historical perspective on how the field evolved as medicine learned more about HCM.

In this insightful interview, Rawan Amir, MBBS, and CardioNerds Academy Fellow, spoke with Milind Desai, MD, MBA, ...

As novel therapeutic agents such as Mavacamten and Tafamidis are developed and become clinically useful for patients ...

New pharmacological agent reduces need for septal reduction therapy in patients with symptomatic obstructive ...

Devesh Rai, MDHypertrophic Cardiomyopathy | May 2, 2023

Historically, early detection of hypertrophic cardiomyopathy (HCM) has been challenging, and prior artificial ...

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Clinical and echo expert Dr. Jose Madrazo discusses a high yield and practical approach to diagnose HCM.

CardioNerdsHypertrophic Cardiomyopathy | April 28, 2023

Dr. Fatimah Alkhunaizi and the CardioNerds discuss pathophysiology, diagnosis, imaging, and management of HCM.

CardioNerds Rounds Co-Chair, Dr. Karan Desai, joins Dr. Michelle Kittleson to discuss hypertrophic cardiomyopathy.

CardioNerds (Amit Goyal, Daniel Ambinder, Carine Hamo, and Karan Desai) are honored to bring to you the Braunwald ...